Life Sciences Firm Working on Diabetes Cure
August 31, 2010
An Indiana company believes it is developing a potential cure for Type I diabetes. Ikotech, currently located at the Purdue Research Park of Southeast Indiana, utilizes technology used in the diagnostics of other diseases to turn pancreatic donations into viable tissues for patients. President David Kennedy talks to Inside INdiana Business Host Gerry Dick about the company.
Ikotech is a spinoff of Greenville-based Techshot Inc. and relocated from Ohio to Indiana to partner with Purdue University and its life sciences researchers.
February 18, 2015
Congratulations to Dr. Joseph Irudayaraj, Deputy Director of the Bindley Bioscience Center, for the 2015 College of Engineering, Research Excellence Award.Read Full Story
January 30, 2015
Enterovirus D68 (EV-D68) is a causative agent of recent outbreaks of respiratory illness in children in the United States. Purdue researchers have shown that pleconaril, a capsid-binding compound that had been developed as an anti-rhinovirus drug, binds and inhibits EV-D68, suggesting that pleconaril may be a possible drug candidate to alleviate EV-D68 outbreaks. The results were reported in the January issue of the journal Science.Read Full Story
January 12, 2015
Five Purdue University researchers received nearly $150,000 from the Trask Innovation Fund to further develop their technologies. The innovations originate from multiple disciplines and range from water purification to a drug-delivery technology.Read Full Story